NL-OMON42212
Recruiting
Not Applicable
Clinical, experimental, and genetic studies on the etiology of central serous chorioretinopathy - Studies on the etiology of central serous chorioretinopathy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- central serous chorioretinopathy
- Sponsor
- eids Universitair Medisch Centrum
- Enrollment
- 825
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All participants will be aged above 18 years.;1\) Genetic analysis and ophthalmological examination in a CSC patient cohort, and in known families with CSC.
- •\* Sporadic CSC: CSC patients who visit or visited the outpatient clinic of the Department of Ophthalmology in either the Leiden University Medical Center or the Rotterdam Eye Hospital.
- •\* Familial CSC: CSC patients, who have at least one family member in whom CSC has been detected. ;2\) Analysis of serum complement activity in CSC patients and in a healthy control group.
- •\* CSC patients who visit the outpatient clinic of the Department of Ophthalmology in the Leiden University Medical Center. Per patient a control will be recruited. For example, the husband or wife of each CSC patient who visits the outpatient clinic of the department of Ophthalmology.;3\) Endocrinological analysis of cortisol and testosterone exposure and sensitivity in CSC patients and in controls.
- •\* CSC patients who visit the outpatient clinic of the Department of Ophthalmology in the Leiden University Medical Center will be referred to the outpatient clinic of the Department of Endocrinology. ;4\) Analysis of the retinal phenotype and choroidal thickness in patients with Cushing\*s syndrome, Conn\*s syndrome, patients who receive solumedrol (a corticosteroid) during acute rejection of a renal transplant, or post renal transplantation patients who receive corticosteroids.
- •\* Patients with Cushing\*s syndrome or Conn\*s syndrome who visit or visited the outpatient clinic of the Department of Endocrinology and are willing to take part in this study.
- •\* Patients receiving solumedrol during acute rejection of a renal transplant, or post renal transplantation patients who receive corticosteroids, who visit or visited the outpatient clinic of the Department of Nephrology and are willing to take part in this study.
Exclusion Criteria
- •For our study no exclusion criteria are applicable.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
To study and evaluate the efficacy of Manjishthadi Tail and Manjishthadi Cream in the management of Acne.CTRI/2022/06/043539IA
Active, not recruiting
Not Applicable
Investigation of clinical, serological and genetic risk factors of severe osteoarthritisM16.0M19.0Primary coxarthrosis, bilateralPrimary arthrosis of other jointsDRKS00003334udwig Boltzmann Institut für Osteologie1. Medizinische AbteilungHanusch Krankenhaus1,001
Recruiting
Not Applicable
Intervention of Haritakyadi kwath in the management of urinary tract infectioHealth Condition 1: N390- Urinary tract infection, site notspecifiedCTRI/2021/06/034369RGGPG Principal RGG PG Ayu Ayurvedic College and Hospital Paprola
Recruiting
Not Applicable
Identification of molecular biomarkers of untreated follicular lymphoma treated by GB therapy.JPRN-jRCT1060200019Maeda Yoshinobu200
Recruiting
Not Applicable
Clinical trials for the safety and efficacy of the combination of XELOX,the colorectal cancer radical resection adjuvant chemotherapy and of chronic hepatitis therapeutic agent 3 oxygelmillpropionic acid polymer.(Phase 1 test)Colorectal cancerJPRN-UMIN000022440Osaka University Hospital5